Blood platelet kinetics in normal subjects modelled by compartmental analysis

Abstract

The purpose of this study was to describe the function of platelets throughout their life span by expressing their in vivo distribution and kinetic behaviour in mathematical terms by using multicompartmental analysis. The distribution of indium-111 labelled platelets in five normal subjects was imaged and quantified with a scintillation camera image processing system. Serial blood samples were also obtained. The data were modelled using the SAAM (Simulation Analysis and Modelling) compartmental computer program. Five models were entertained to evaluate the role of platelets that were either functional or injured during collection and their interaction with the liver, spleen and vascular endothelium. Models were evaluated by comparing F values calculated from the least squares estimate obtained from each model. The Dornhorst function was used to describe the sequestration of platelets in the compartmental model. Results indicated that the data could not be satisfactorily simulated when compartments were included that simulated only functional and sequestered platelets (model 1). It was necessary to include compartments that simulated the kinetics of collection-injured platelets in the liver (model 2) and spleen (model 3). The model that simulated the interaction with the vascular endothelium (model 5) showed a visual but not significant improvement in the fitting of the observed data compared to model 3. The mean organ uptake and range indicated in parentheses were calculated at equilibrium. There were 20% (15%-27%) of the injected platelets in the spleen, 10% (8%-11%) in the liver and 70% (64%-75%) in the circulation.(ABSTRACT TRUNCATED AT 250 WORDS)

Platelets as Predictors of Vascular Risk: Is There a Practical Index of Platelet Activity?

“…Radionuclides commonly used for this purpose were chromium-51 (51Cr), indium-111 ("'1In), and rarely selenium-75 (75Se) and carbon-14 (14C). Using 11'In, 70% of the autologous platelets were distributed in the circulation, while the remaining were distributed to the spleen (20%) and liver (10%) (113).…”

Kinetics of111In-labeled bleomycin in patients with brain tumors: Compartmental vs. non-compartmental models

“…[1][2][3][4][5][6][7][8][9] The basic considerations of compartmental models and detailed solving of a general three-compartmental model have been presented by Rubinow and Wintzer. 10 In non-compartment analysis (black-box analysis) no compartments are im- I male 53 high GB4 primary 2 male 43 -MA primary 3 female 48 high 02 recurrent 4 male 62 high GB4 primary 5 male 44 high AA3 primary 6 female 52 high 02 recurrent 7 male 53 high GB4 recurrent 8 male 41 high A03 recurrent 9 male 38 low 02 primary 10 male 32 low OA2 primary 11 female 70 -MET primary 12 male 66 high GB4 primary * Histology: GB = glioblastoma multiforme; 0 = oligodendroglioma; AA = anaplastic astrocytoma; AO = anaplastic oligodendroglioma; OA = oligoastrocytoma; MA = atypical meningioma; MET = adenocarcinoma; 2, 3, 4 = WHO grades specific cytotoxic effects as it breaks the DNA in the G2 and M phases.…”